2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide

C31H38N6O7S — CID 165419621

IUPAC2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide
SMILESCOCc1nnc(NC(=O)CN2CC[C@@H]3NC(=O)CN(C)C(=O)CCc4ccc(c(OC)c4)Oc4cccc(c4)CO[C@H]3C2)s1
InChIInChI=1S/C31H38N6O7S/c1-36-16-27(38)32-23-11-12-37(17-28(39)33-31-35-34-29(45-31)19-41-2)15-26(23)43-18-21-5-4-6-22(13-21)44-24-9-7-20(8-10-30(36)40)14-25(24)42-3/h4-7,9,13-14,23,26H,8,10-12,15-19H2,1-3H3,(H,32,38)(H,33,35,39)/t23-,26-/m0/s1
InChIKeyUFPCFVOMHLTDFY-OZXSUGGESA-N
MW638.75 g/mol
LogP2.60
Rot. Bonds6

About 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide

2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide (PubChem CID 165419621) has the molecular formula C31H38N6O7S and a molecular weight of 638.75 g/mol. Its IUPAC name is 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide.

Molecular Properties

Compound Name2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide
PubChem CID165419621
Molecular FormulaC31H38N6O7S
Molecular Weight638.75 g/mol
Exact Mass638.25
IUPAC Name2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide
SMILESCOCc1nnc(NC(=O)CN2CC[C@@H]3NC(=O)CN(C)C(=O)CCc4ccc(c(OC)c4)Oc4cccc(c4)CO[C@H]3C2)s1
InChIInChI=1S/C31H38N6O7S/c1-36-16-27(38)32-23-11-12-37(17-28(39)33-31-35-34-29(45-31)19-41-2)15-26(23)43-18-21-5-4-6-22(13-21)44-24-9-7-20(8-10-30(36)40)14-25(24)42-3/h4-7,9,13-14,23,26H,8,10-12,15-19H2,1-3H3,(H,32,38)(H,33,35,39)/t23-,26-/m0/s1
InChIKeyUFPCFVOMHLTDFY-OZXSUGGESA-N
XLogP2.60
TPSA144.45 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500638.75
LogP ≤ 52.60
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Analyze 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide?
The IUPAC name of 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide (CID 165419621) is 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide.
What is the SMILES notation for 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide?
The canonical SMILES for 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide is COCc1nnc(NC(=O)CN2CC[C@@H]3NC(=O)CN(C)C(=O)CCc4ccc(c(OC)c4)Oc4cccc(c4)CO[C@H]3C2)s1.
What is the InChIKey of 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide?
The InChIKey is UFPCFVOMHLTDFY-OZXSUGGESA-N. The full InChI is InChI=1S/C31H38N6O7S/c1-36-16-27(38)32-23-11-12-37(17-28(39)33-31-35-34-29(45-31)19-41-2)15-26(23)43-18-21-5-4-6-22(13-21)44-24-9-7-20(8-10-30(36)40)14-25(24)42-3/h4-7,9,13-14,23,26H,8,10-12,15-19H2,1-3H3,(H,32,38)(H,33,35,39)/t23-,26-/m0/s1.
What are the key properties of 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide?
2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide has a molecular weight of 638.75 g/mol, XLogP of 2.60, 6 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(10S,15S)-25-methoxy-19-methyl-17,20-dioxo-2,9-dioxa-12,16,19-triazatetracyclo[21.2.2.13,7.010,15]octacosa-1(25),3,5,7(28),23,26-hexaen-12-yl]-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]acetamide is sourced from PubChem (CID 165419621), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).